Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Medical System Holdings Ltd. (HK:0867)
HKEX:0867
China Medical System Holdings (0867) Stock Price & Analysis
2 Followers
0867 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$6.23 - HK$15.86
Previous CloseHK$6.41
Volume2.08M
Average Volume (3M)12.63M
Market Cap
HK$15.64B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)5.9
Beta0.94
Next Earnings
Aug 26, 2024EPS Estimate
HK$0.35Last Dividend Ex-Date
May 13, 2024Dividend Yield6.68%
Share Statistics
EPS (TTM)1.10
Shares Outstanding2,451,988,512
10 Day Avg. Volume3,255,000
30 Day Avg. Volume12,633,711
Standard Deviation0.10
R-Squared0.09
Alpha-0.00021
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Medical System Holdings News
PremiumCompany Announcements
China Medical System’s Lumeblue® Wins Approval
Options Prices
Currently, No data available
---
Ownership Overview
53.36% Insiders
4.08% Mutual Funds
2.83% Other Institutional Investors
39.73% Public Companies and
Individual Investors
0867 FAQ
What was China Medical System Holdings Ltd.’s price range in the past 12 months?
China Medical System Holdings Ltd. lowest stock price was HK$6.23 and its highest was HK$15.86 in the past 12 months.
What is China Medical System Holdings Ltd.’s market cap?
Currently, no data Available
When is China Medical System Holdings Ltd.’s upcoming earnings report date?
China Medical System Holdings Ltd.’s upcoming earnings report date is Aug 26, 2024 which is in 29 days.
How were China Medical System Holdings Ltd.’s earnings last quarter?
China Medical System Holdings Ltd. released its earnings results on Mar 27, 2024. The company reported HK$0.216 earnings per share for the quarter, missing the consensus estimate of HK$0.582 by -HK$0.367.
Is China Medical System Holdings Ltd. overvalued?
According to Wall Street analysts China Medical System Holdings Ltd.’s price is currently Overvalued.
Does China Medical System Holdings Ltd. pay dividends?
China Medical System Holdings Ltd. pays a Annually dividend of HK$0.09 which represents an annual dividend yield of 6.68%. See more information on China Medical System Holdings Ltd. dividends here
What is China Medical System Holdings Ltd.’s EPS estimate?
China Medical System Holdings Ltd.’s EPS estimate is HK$0.35.
How many shares outstanding does China Medical System Holdings Ltd. have?
China Medical System Holdings Ltd. has 2,439,528,600 shares outstanding.
What happened to China Medical System Holdings Ltd.’s price movement after its last earnings report?
China Medical System Holdings Ltd. reported an EPS of HK$0.216 in its last earnings report, missing expectations of HK$0.582. Following the earnings report the stock price went up 0.162%.
Which hedge fund is a major shareholder of China Medical System Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0867
---
China Medical System Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.75%
12-Months-Change
Fundamentals
Return on Equity
16.02%
Trailing 12-Months
Asset Growth
-2.11%
Trailing 12-Months
Company Description
China Medical System Holdings Ltd.
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.
---
0867 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Chugai Pharmaceutical Co
―
AstraZeneca
―
GlaxoSmithKline
―
Novartis
―
China Medical System Holdings
―
Best Analysts Covering 0867
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-23.70%
reiterated a buy rating 4 months ago
Copying Michael Luo CFA's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -23.70% per trade.
---